Phase II evaluation of 5-fluorouracil, folinic acid and cisplatin in advanced-stage colorectal adenocarcinoma.

Abstract:

:Twenty-seven patients with advanced measurable colorectal carcinoma were treated with a combination protocol consisting of folinic acid (FA) 200 mg/m2 i.v. bolus followed by 5-fluorouracil (5-FU) 550 mg/m2, and cisplatin (CIS) 20 mg/m2 each administered as a 2-hour i.v. infusion. Treatment was given on 4 consecutive days at 3- to 4-weekly intervals. Of 25 evaluable patients, 1 achieved complete remission and 5 partial remission for an overall response rate of 24%, while 9 patients (36%) had stable disease. Two out of 6 responders had previously progressed on 5-FU-containing regimens. The 95% confidence interval for response is 7-41%. Median survival time for all 27 patients enrolled in the study is 27+ weeks. Tolerance was remarkable and consisted primarily of mild and reversible gastrointestinal symptoms and myelosuppression. This 3-drug-regimen had significant palliative activity in our patient population. Its definitive role in the treatment of metastatic colorectal cancer as well as the potential improvement of the therapeutic index of 5-FU/FA by addition of CIS, require further evaluation in a randomized phase III trial.

journal_name

Oncology

journal_title

Oncology

authors

Scheithauer W,Depisch D,Schiessel R,Ludwig H

doi

10.1159/000226719

subject

Has Abstract

pub_date

1989-01-01 00:00:00

pages

217-21

issue

4

eissn

0030-2414

issn

1423-0232

journal_volume

46

pub_type

杂志文章

相关文献

ONCOLOGY文献大全
  • Effect of 1(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) on Sato lung carcinoma (SLC). Preliminary result of immunochemotherapy for SLC by combination of ACNU and Propionibacterium acnes.

    abstract::ACNU was highly effective for Sato lung carcinoma transplanted intravenously or intramuscularly by using a large single dose, and the cytotoxic action of ACNU for SLC showed clear dependence upon tumor size. Nonspecific activation of host-defence mechanism by Propionibacterium acnes contributed to the suppression for ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225309

    authors: Saijo N,Niitani H,Irimajiri N,Chikama M

    更新日期:1979-01-01 00:00:00

  • Ondansetron: a cost-effective advance in anti-emetic therapy.

    abstract::A cost-effectiveness analysis is one form of full economic evaluation where drug acquisition costs and the costs that are incurred as a result of using a particular treatment are assessed together with clinical efficacy. This paper reviews two such studies. One of the studies was a prospective randomised cost-effectiv...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000227175

    authors: Cox F,Hirsch J

    更新日期:1993-05-01 00:00:00

  • Prognostic significance of p27(kip1) protein expression and spontaneous apoptosis in patients with colorectal adenocarcinomas.

    abstract::Tumor cell apoptosis, proliferation and p27 expression using an in situ apoptosis detection kit, anti-Ki67 antibody and anti-p27 antibody were investigated in 171 colorectal adenocarcinoma specimens, together with the assessment of mutated p53 expression. No apparent association was observed among p27 expression, muta...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000012078

    authors: Tenjo T,Toyoda M,Okuda J,Watanabe I,Yamamoto T,Tanaka K,Ohtani M,Nohara T,Kawasaki H,Tanigawa N

    更新日期:2000-01-01 00:00:00

  • Long-term follow-up of patients with advanced ovarian carcinoma treated with debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide. Gynecologic Oncology Group of the Comprehensive Cancer Center.

    abstract::Between June 1980 and December 1984, 88 patients with stage III-IV ovarian carcinoma were entered in a study evaluating the role of debulking surgery and chemotherapy consisting of cyclophosphamide, doxorubicin, and cisplatin intravenously on day 1, every 4 weeks (CAP-1). The results after a median follow-up of 62 mon...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226801

    authors: Wils JA

    更新日期:1990-01-01 00:00:00

  • Expression of the high-affinity fluoropyrimidine-preferring nucleoside transporter hCNT1 correlates with decreased disease-free survival in breast cancer.

    abstract:PURPOSE:Nucleoside and nucleobase derivatives are currently used in the treatment of a variety of solid tumors; however, the role of plasma membrane transporters as biomarkers of drug metabolism has not been fully addressed. Thus, the purpose of this study was to determine whether the concentrative nucleoside transport...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000094541

    authors: Gloeckner-Hofmann K,Guillén-Gómez E,Schmidtgen C,Porstmann R,Ziegler R,Stoss O,Casado FJ,Rüschoff J,Pastor-Anglada M

    更新日期:2006-01-01 00:00:00

  • Dose escalation study of paclitaxel in combination with fixed-dose irinotecan in patients with advanced non-small cell lung cancer (JCOG 9807).

    abstract:BACKGROUND:Both irinotecan (CPT) and paclitaxel (Pac) are effective against non-small cell lung cancer (NSCLC), and besides, preclinical studies have demonstrated an additive or synergistic interaction between camptothecin and taxane. METHODS:We conducted a phase I/II study of combination chemotherapy consisting of Pa...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000077434

    authors: Yamada K,Ikehara M,Tanaka G,Nomura I,Oshita F,Noda K

    更新日期:2004-01-01 00:00:00

  • Reduced expression of manganese superoxide dismutase mRNA may correlate with invasiveness in esophageal carcinoma.

    abstract::Little is known about the expression and antioxidant function of manganese superoxide dismutase (Mn-SOD) in esophageal squamous cell carcinoma. To determine the significance of Mn-SOD in esophageal squamous cell carcinomas, Mn-SOD mRNA expression was examined in 45 esophageal squamous cell carcinomas and the correspon...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000012165

    authors: Toh Y,Kuninaka S,Mori M,Oshiro T,Ikeda Y,Nakashima H,Baba H,Kohnoe S,Okamura T,Sugimachi K

    更新日期:2000-09-01 00:00:00

  • Cancer in humans: exposures and responses in a real world.

    abstract::Cancer causation in humans is at least a three-dimensional problem too often viewed from only two dimensions, especially as far as the two-dimensional results (dose versus response) of cancer induction tests in animals are viewed. The expression of a cancer represents a critical convergence of additional factors in th...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000225113

    authors: Kolbye AC Jr

    更新日期:1976-01-01 00:00:00

  • Effect of reoxygenation on the hypoxia-induced up-regulation of serine protease inhibitor PAI-1 in head and neck cancer cells.

    abstract::In squamous cell carcinoma of the head and neck (SCCHN), hypoxia is considered a crucial physiological modulator for malignant progression, wherebythe plasminogen activation system is involved in overlapping functions such as moulding of the extracellular matrix, cell proliferation and signal transduction. Little is k...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000106789

    authors: Sprague LD,Mengele K,Schilling D,Geurts-Moespot A,Sweep FC,Stadler P,Schmitt M,Molls M

    更新日期:2006-01-01 00:00:00

  • Long-term cosmetic outcome and toxicity in patients treated with quadrantectomy and radiation therapy for early-stage breast cancer.

    abstract::Breast conservation treatment followed, if useful, by adjuvant therapy is the treatment of choice in early breast cancer. Late cosmetic outcome and toxicity are important in comparing conservative treatment to mastectomy. We reviewed the records of 225 patients treated from 1981 to 1988 with a median follow-up of 74 m...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227454

    authors: Amichetti M,Busana L,Caffo O

    更新日期:1995-05-01 00:00:00

  • Tumor-Infiltrating Lymphocytes in Biopsy Specimens Obtained 7 Days after Starting Chemoradiotherapy for Rectal Cancer Are Predictors of the Response to Chemoradiotherapy.

    abstract:BACKGROUND:Neoadjuvant chemoradiotherapy (nCRT) followed by total mesorectal excision surgery is a standard treatment for locally advanced rectal cancer (LARC). Tumor-infiltrating lymphocytes (TILs) have been reported to be associated with tumor response; however, this remains to be established. We previously reported ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000508922

    authors: Miyakita H,Sadahiro S,Suzuki T,Chan LF,Ogimi T,Okada K,Yamamoto S,Kajiwara H

    更新日期:2020-01-01 00:00:00

  • Local interleukin-2 therapy for cancer, and its effector induction mechanisms.

    abstract::This paper reviews the effectiveness of local interleukin-2 (IL-2) therapy and its effector induction mechanisms in vivo. Local therapy with IL-2 and/or lymphokine-activated killer (LAK) cells is associated with far fewer side effects than systemic treatment. Local infusions of IL-2 into malignant pleural effusions an...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000227331

    authors: Sone S,Ogura T

    更新日期:1994-03-01 00:00:00

  • Palliative chemotherapy in non-Hodgkin's lymphoma.

    abstract:GOALS OF WORK:There is a need for an effective and nontoxic chemotherapy for palliative indication in non-Hodgkin's lymphoma (NHL) patients who relapse after conventional or high-dose chemotherapy. The aim of this study was to investigate the feasibility and efficacy of peroral chemotherapy in the palliative treatment ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227672

    authors: Salminen E,Nikkanen V,Lindholm L

    更新日期:1997-03-01 00:00:00

  • Do recurrent and metastatic pancreatic cancer patients have the same outcomes with gemcitabine treatment?

    abstract:BACKGROUND:Whether recurrence after surgery and primary metastatic pancreatic cancer should be included in the same category when conducting gemcitabine-based clinical trials remains controversial. OBJECTIVE:To clarify the outcomes of recurrent and metastatic pancreatic cancers. METHODS:326 patients who received gemc...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000236022

    authors: Hashimoto K,Ueno H,Ikeda M,Kojima Y,Hagihara A,Kondo S,Morizane C,Okusaka T

    更新日期:2009-01-01 00:00:00

  • Phase IV study of bevacizumab in combination with infusional fluorouracil, leucovorin and irinotecan (FOLFIRI) in first-line metastatic colorectal cancer.

    abstract:BACKGROUND:Bevacizumab (Avastin) significantly improves overall survival (OS) and progression-free survival (PFS) when combined with first-line irinotecan (IFL) plus bolus 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic colorectal cancer (CRC). This open-label, phase IV trial evaluated the efficac...

    journal_title:Oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1159/000229787

    authors: Sobrero A,Ackland S,Clarke S,Perez-Carrión R,Chiara S,Gapski J,Mainwaring P,Langer B,Young S,AVIRI Trial investigators.

    更新日期:2009-01-01 00:00:00

  • Phase II trial of alternating mFOLFOX6 and FOLFIRI regimens in the first-line treatment for unresectable or metastatic colorectal cancer (KSCC0701).

    abstract:OBJECTIVE:This phase II study examined the efficacy and safety of alternating regimens of mFOLFOX6 and FOLFIRI as a first-line treatment for unresectable or metastatic colorectal cancer. PATIENTS AND METHODS:Forty-eight patients were enrolled in this study. Patients received an alternating regimen of 4 cycles of mFOLF...

    journal_title:Oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1159/000346690

    authors: Oki E,Emi Y,Akagi Y,Tokunaga S,Sadanaga N,Tanaka T,Ogata Y,Saeki H,Kakeji Y,Baba H,Nishimaki T,Natsugoe S,Shirouzu K,Maehara Y,Kyushu Study Group of Clinical Cancer.

    更新日期:2013-01-01 00:00:00

  • Cardiac Troponin I Predicts Elevated B-type Natriuretic Peptide in Patients Treated with Anthracycline-Containing Chemotherapy.

    abstract:BACKGROUND:Anthracycline is used to treat various types of cancer; however, cardiotoxicity negatively affects patient prognosis. OBJECTIVES:The aim of the present study was to investigate serial changes in levels of cardiac troponin I (TnI) and B-type natriuretic peptide (BNP) in patients treated with anthracycline-co...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000507585

    authors: Oikawa M,Yoshihisa A,Yokokawa T,Misaka T,Yaegashi D,Miyata M,Nakazato K,Ishida T,Takeishi Y

    更新日期:2020-01-01 00:00:00

  • Gastric non-Hodgkin's lymphoma after successful treatment of Hodgkin's disease.

    abstract::A patient seen at presentation for Hodgkin's disease (HD) at stage IV B was successfully treated with MOPP. In remission he developed coeliac disease, controlled by dietary measures, but 26 months after the end of chemotherapy a severe dyspeptic syndrome appeared; endoscopy and barium meal suggested the presence of a ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226345

    authors: Eridani S,Singh AK

    更新日期:1986-01-01 00:00:00

  • Prognostic factors and outcomes in 28 cases of uterine leiomyosarcoma.

    abstract:OBJECTIVES:It was the aim of this study to evaluate clinicopathological characteristics and prognostic factors of uterine leiomyosarcomas (LMS). METHODS:Twenty-eight patients with uterine LMS were evaluated in this retrospective study. Their features and survival were analyzed by Kaplan-Meier and log-rank tests. RESU...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000331679

    authors: Loizzi V,Cormio G,Nestola D,Falagario M,Surgo A,Camporeale A,Putignano G,Selvaggi L

    更新日期:2011-01-01 00:00:00

  • Fetal antigens in the precursor stages of gastric cancer.

    abstract::Gastric epithelial cells, identified in biopsy specimens from individuals with varying degrees of gastritis and cellular atypia, were classified according to morphology and reactivity with an adult tissue-absorbed rabbit antibody to 2nd trimester human fetal tissue. Sections of stomach from normal individuals and pati...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225796

    authors: Higgins PJ,Correa P,Cuello C,Lipkin M

    更新日期:1984-01-01 00:00:00

  • A case-control study of breast cancer and psychotropic drug use.

    abstract::The relative risk of breast cancer incidence and tumor promotion associated with psychotropic drug consumption was evaluated in 151 patients with newly diagnosed neoplasms and 151 hospital controls. No significantly altered risk of breast cancer was found in association with the use of diazepam, chlordiazepoxide, anti...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225651

    authors: Wallace RB,Sherman BM,Bean JA

    更新日期:1982-01-01 00:00:00

  • Costs associated with capecitabine or 5-fluorouracil monotherapy after surgical resection in patients with colorectal cancer.

    abstract:OBJECTIVE:To compare chemotherapy-related and total medical costs among patients with colorectal cancer (CRC) receiving capecitabine or 5-fluorouracil (5-FU) monotherapy after surgical resection. METHODS:This retrospective, claim-based study utilized the Thomson Reuters Market Scan(R) databases to identify 1,396 CRC p...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000236048

    authors: Chu E,Shi N,Wei W,Bendell JC,Cartwright T

    更新日期:2009-01-01 00:00:00

  • Aspirin shares a short-term effect, inhibition of pyruvate kinase activity with tumor-promoting agents, but fails to promote rat liver carcinogenesis.

    abstract::Since aspirin was found to cause a persistent decrease in pyruvate kinase activity, which is a prominent characteristic of the hepatic promoters, the effect of aspirin on hepatic tumorigenesis in the rat has been studied. Male Wistar rats were initiated with a diet containing 0.06% 3'-methyl-4-dimethylamino-azobenzene...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227195

    authors: Yanagi S,Yamashita M,Hiasa Y

    更新日期:1993-07-01 00:00:00

  • Prognostic Factors in HER2-Positive Primary Breast Cancer Patients Treated Using Neoadjuvant Chemotherapy Plus Trastuzumab.

    abstract:BACKGROUND:It is unclear for whom new anti-human epidermal growth factor receptor 2 (anti-HER2) agents, such as pertuzumab and T-DM1, should be considered. We investigated prognostic factors before neoadjuvant chemotherapy (NAC) among HER2-positive invasive breast cancer patients and those after NAC among patients who ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000502910

    authors: Fujita N,Enomoto Y,Inakami K,Yanagisawa T,Iguchi C,Aono T,Nomura T,Yamamoto H,Kasugai T,Shiba E

    更新日期:2020-01-01 00:00:00

  • Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian Cancer.

    abstract:OBJECTIVE:Ovarian cancer is the most lethal gynecological malignancy, but information relevant to prognosis and outcomes remain unknown. Here, we used statistical methods to focus specifically on interactions between candidate prognostic variables. METHODS AND RESULTS:Univariate, multivariate, and elastic net modeling...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000442710

    authors: Jatoi A,Vierkant RA,Hawthorne KM,Block MS,Ramus SJ,Larson NB,Fridley BL,Goode EL

    更新日期:2016-01-01 00:00:00

  • Administration of vincristine in a patient with Machado-Joseph disease.

    abstract::Chemotherapy-induced peripheral neurotoxicity is a major problem because it represents the dose-limiting side effect of a significant number of antineoplastic drugs, such as vinca alkaloids. Hereditary neuropathies usually predispose to severe vincristine neurotoxicity. Here, we report the case of a 56-year-old man wi...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000336602

    authors: Colpo A,Wilson FH,Nardi V,Hochberg E

    更新日期:2012-01-01 00:00:00

  • Boron neutron capture therapy of cerebral gliomas. II. Utilization of the blood-brain barrier and tumor-specific antigens for the selective concentration of boron in gliomas.

    abstract::The use of the blood-brain barrier and of tumor-specific antibodies to concentrate boron selectivity in gliomas for neutron capture therapy is considered experimentally and theoretically. The time-dependent concentration of two anionic boranes, B12 H11 SH2- and B12 H11 SOSB12 H114-, in the blood, brain, and tumor of ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225073

    authors: Tolpin EI,Wellum GR,Dohan FC Jr,Kornblith PL,Zamenhof RG

    更新日期:1975-01-01 00:00:00

  • Functionally active duplications of the CYP2D6 gene are more prevalent among larynx and lung cancer patients.

    abstract::The cytochrome P450 CYP2D6 is a polymorphic drug-metabolizing enzyme that is involved in the metabolism of several drugs and xenobiotics. Several independent studies indicate that the CYP2D6 metabolic status is a secondary factor in the risk of developing lung cancer, with individuals with high activity being at incre...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000055354

    authors: Agúndez JA,Gallardo L,Ledesma MC,Lozano L,Rodriguez-Lescure A,Pontes JC,Iglesias-Moreno MC,Poch J,Ladero JM,Benítez J

    更新日期:2001-01-01 00:00:00

  • Lack of c-mpl proto-oncogene transcripts and growth-stimulatory effects of thrombopoietin on human small cell lung cancer cell lines.

    abstract::Thrombopoietin (TPO) is a recently discovered hematopoietic growth factor which stimulates the production and maturation of megakaryocytes. In this study, we used a modified MTT assay to examine the in vitro growth-stimulatory effects of recombinant human (rh) TPO and recombinant human stem cell factor (rhSCF) on eigh...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227600

    authors: Shinohara A,Shimizu E,Takada M,Sone S

    更新日期:1996-09-01 00:00:00

  • Haematological evaluation of weekly therapy with topotecan for the treatment of recurrent ovarian cancer resistant to platinum-based therapy.

    abstract::Topotecan is indicated in the treatment of advanced-stage ovarian cancers refractory to prior platinum-based regimen. The aim of this study was to compare the standard therapeutic strategy with a novel strategy of weekly administration of topotecan. The primary endpoints were dose density and overall tolerance. This r...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000127384

    authors: Largillier R,Valenza B,Ferrero JM,Novo C,Creisson A,Lesbats G,Mari V,Hebert C,Chamorey E

    更新日期:2007-01-01 00:00:00